Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chimera Antigen Receptor (CAR)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03373097
What this trial is testing

Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or Other GD2-positive Solid Tumors

Who this might be right for
NeuroblastomaNeuroblastoma RecurrentGD2-positive Solid Tumors+3 more
Bambino Gesù Hospital and Research Institute 42
Early research (Phase 1)Looking for participantsNCT07066397
What this trial is testing

FIT-CD19-CAR-T Cells in R/R B-ALL

Who this might be right for
Acute Lymphoblastic Leukemia
TriArm Therapeutics (Taiwan) Limited 12
Very early researchActive Not RecruitingNCT06228404
What this trial is testing

Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC

Who this might be right for
Metastatic Castration-resistant Prostate CancerCastration-resistant Prostate Cancer
Shanghai Changzheng Hospital 18
Not applicableLooking for participantsNCT04888338
What this trial is testing

Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies

Who this might be right for
Hematopoietic and Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center 100
Early research (Phase 1)Ended earlyNCT04633148
What this trial is testing

Dose-escalating Trial With UniCAR02-T Cells and PSMA Target Module (TMpPSMA) in Patients With Progressive Disease After Standard Systemic Therapy in Cancers With Positive PSMA Marker

Who this might be right for
Prostate Cancer
AvenCell Europe GmbH 16
Early research (Phase 1)Ended earlyNCT06343376
What this trial is testing

Genetically Engineered Cells (EGFRt/19-28z/IL-12 CAR T Cells) for the Treatment of Relapsed or Refractory CD19+ Hematologic Malignancies

Who this might be right for
Recurrent Chronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell LymphomaRecurrent Follicular Lymphoma+11 more
Roswell Park Cancer Institute 1
Early research (Phase 1)UnknownNCT06254807
What this trial is testing

CAR-monocytes for the Treatment of HER2 Overexpressing Solid Tumors

Who this might be right for
HER2-positive
Carisma Therapeutics Inc 6
Testing effectiveness (Phase 2)Looking for participantsNCT06718244
What this trial is testing

Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1

Who this might be right for
Acute Lymphoblastic Leukemia
Ruijin Hospital 20
Not applicableLooking for participantsNCT04300998
What this trial is testing

Study of CAR-T Therapy in Older Patients

Who this might be right for
LymphomaRefractory B-Cell LymphomaLymphoma, B-Cell+3 more
Memorial Sloan Kettering Cancer Center 154
Early research (Phase 1)Looking for participantsNCT06340737
What this trial is testing

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

Who this might be right for
Follicular LymphomaMantle Cell LymphomaHairy Cell Leukemia+5 more
Stanford University 148
Early research (Phase 1)Active Not RecruitingNCT06544330
What this trial is testing

SYNCAR-001 + STK-009 Without Conditioning Chemotherapy (Lymphodepletion) in Subjects With Severe, Refractory Systemic Autoimmune Rheumatic Disease

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisSystemic Sclerosis
Synthekine 48
Early research (Phase 1)Looking for participantsNCT07493044
What this trial is testing

An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)GPC3 Positive Hepatocellular Carcinoma
Guangzhou FineImmune Biotechnology Co., LTD. 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT03271632
What this trial is testing

Multi-CAR T Cell Therapy in the Treatment of Multiple Myeloma

Who this might be right for
Multiple Myeloma
Shenzhen Geno-Immune Medical Institute 20
Very early researchLooking for participantsNCT04561557
What this trial is testing

Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System

Who this might be right for
Autoimmune DiseasesAutoimmune Diseases of the Nervous SystemNeuromyelitis Optica Spectrum Disorder+7 more
Tongji Hospital 36
Early research (Phase 1)WithdrawnNCT04952584
What this trial is testing

Allogeneic CD30 Chimeric Antigen Receptor Epstein-Barr Virus-Specific T Lymphocytes in Relapsed or Refractory CD30-Positive Lymphomas

Who this might be right for
Extranodal Natural Killer/T-Cell Lymphoma, Nasal TypeClassical Hodgkin Lymphoma
Baylor College of Medicine
Early research (Phase 1)Looking for participantsNCT06096038
What this trial is testing

Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC

Who this might be right for
Head and Neck CancerRelapseRecurrent+1 more
UNC Lineberger Comprehensive Cancer Center 33
Very early researchEnded earlyNCT02640209
What this trial is testing

Pilot Trial Of Autologous T Cells Engineered To Express Anti-CD19 Chimeric Antigen Receptor (CART19)In Combination With Ibrutinib In Patients With Relapsed Or Refractory CD19+ Chronic Lymphocytic Leukemia (CLL)Or Small Lymphocytic Lymphoma (SLL)

Who this might be right for
LYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL)
University of Pennsylvania 20
Early research (Phase 1)WithdrawnNCT06429800
What this trial is testing

Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Systemic Lupus Erythematosus

Who this might be right for
Lupus NephritisSystemic Lupus Erythematosus
Atara Biotherapeutics
Testing effectiveness (Phase 2)UnknownNCT02617134
What this trial is testing

CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor

Who this might be right for
Malignant Glioma of BrainColorectal CarcinomaGastric Carcinoma
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 20
Testing effectiveness (Phase 2)UnknownNCT02672501
What this trial is testing

Assess CD19-targeted Immunotherapy T Cells in Patients With Relapsed or Refractory CD19+ B Cell Leukemia

Who this might be right for
Leukemia, B-Cell
Shanghai GeneChem Co., Ltd. 30
Next Page